CEBPA and neoplasm: In animal model, MAP kinase14Δ/ΔKrasG12V mice with extensive lung stem cell numbers and tumor progression have demonstrated decreased C/EBPα expression in vivo, suggesting that C/EBPα is a possible downstream target of MAPK14 (p38α) in the lung [16].